Hospital Sant Joan de Déu Barcelona

Barcelona 8950

3 studies enrolling now · 8 studies all time

What they study most

Acute Myeloid Leukemia, Anti-myostatin, Cardiomyopathy, Dravet Syndrome, Long Bone Fractures, Low-grade Glioma, Neuromuscular Manifestations, Partial Epilepsy, Pediatric Low-grade Glioma, Rapidly Accelerated Fibrosarcoma (RAF) Altered Glioma, Respiratory Syncytial Virus Infections, SMA

Studies at this site

• Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML) — Recruiting now
• A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy — Recruiting now
• Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy — Recruiting now
• DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2) — Running, not enrolling
• Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures — Running, not enrolling
• Registry of Pediatric Orthopedic Trauma and Health Outcomes in Skeletally Immature Children — Running, not enrolling
• A 2-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥ 2 Years Old and Young Adults With Dravet Syndrome — Completed
• Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children — Completed